Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	palmitoyl-CoA ligase activity	ACSL3 ACSL4	3.63e-05	3	70	2	GO:0090433
GeneOntologyMolecularFunction	Notch binding	JAG2 ATRNL1 CCN3	1.14e-04	27	70	3	GO:0005112
Domain	VWFC_1	JAG2 CCN5 SSPOP CCN3	9.19e-06	36	69	4	PS01208
Domain	VWC	JAG2 CCN5 SSPOP CCN3	1.15e-05	38	69	4	SM00214
Domain	VWFC_2	JAG2 CCN5 SSPOP CCN3	1.15e-05	38	69	4	PS50184
Domain	VWF_dom	JAG2 CCN5 SSPOP CCN3	1.72e-05	42	69	4	IPR001007
Domain	EMI	MEGF6 SSPOP PEAR1	3.16e-05	17	69	3	PS51041
Domain	Sushi	PAPPA2 CSMD1 CR1L F13B	4.04e-05	52	69	4	PF00084
Domain	CCP	PAPPA2 CSMD1 CR1L F13B	4.69e-05	54	69	4	SM00032
Domain	SUSHI	PAPPA2 CSMD1 CR1L F13B	5.42e-05	56	69	4	PS50923
Domain	EGF_2	JAG2 MEGF6 ATRNL1 SSPOP F7 PEAR1 EPHA7	5.45e-05	265	69	7	PS01186
Domain	Sushi_SCR_CCP_dom	PAPPA2 CSMD1 CR1L F13B	5.81e-05	57	69	4	IPR000436
Domain	Calreticulin/calnexin_P_dom	CLGN ZNF622	1.34e-04	5	69	2	IPR009033
Domain	RICIN	GALNT8 GALNT5 LY75	1.48e-04	28	69	3	SM00458
Domain	RICIN_B_LECTIN	GALNT8 GALNT5 LY75	1.48e-04	28	69	3	PS50231
Domain	Ricin_B_lectin	GALNT8 GALNT5 LY75	1.82e-04	30	69	3	IPR000772
Domain	Kringle-like	CCN5 PRSS12 LY75	2.22e-04	32	69	3	IPR013806
Domain	EGF_3	JAG2 MEGF6 ATRNL1 SSPOP F7 PEAR1	2.30e-04	235	69	6	PS50026
Domain	Growth_fac_rcpt_	JAG2 CCN5 MEGF6 CCN3 EPHA7	2.79e-04	156	69	5	IPR009030
Domain	EGF_Lam	MEGF6 ATRNL1 PEAR1	2.90e-04	35	69	3	SM00180
Domain	TRYPSIN_SER	PRSS12 CTRB2 CTRB1 F7	3.43e-04	90	69	4	IPR033116
Domain	EGF_1	JAG2 MEGF6 ATRNL1 SSPOP F7 PEAR1	3.57e-04	255	69	6	PS00022
Domain	Laminin_EGF	MEGF6 ATRNL1 PEAR1	3.71e-04	38	69	3	IPR002049
Domain	EGF-like_CS	JAG2 MEGF6 ATRNL1 F7 PEAR1 EPHA7	4.04e-04	261	69	6	IPR013032
Domain	PAZ	PIWIL4 DICER1	4.76e-04	9	69	2	PS50821
Domain	PAZ	PIWIL4 DICER1	4.76e-04	9	69	2	SM00949
Domain	PAZ_dom	PIWIL4 DICER1	4.76e-04	9	69	2	IPR003100
Domain	PAZ	PIWIL4 DICER1	4.76e-04	9	69	2	PF02170
Domain	TRYPSIN_HIS	PRSS12 CTRB2 CTRB1 F7	5.73e-04	103	69	4	IPR018114
Domain	TRYPSIN_SER	PRSS12 CTRB2 CTRB1 F7	6.38e-04	106	69	4	PS00135
Domain	TRYPSIN_HIS	PRSS12 CTRB2 CTRB1 F7	6.61e-04	107	69	4	PS00134
Domain	Insulin_GF-bd_Cys-rich_CS	CCN5 CCN3	7.24e-04	11	69	2	IPR017891
Domain	Peptidase_S1A	PRSS12 CTRB2 CTRB1 F7	8.11e-04	113	69	4	IPR001314
Domain	TRYPSIN_DOM	PRSS12 CTRB2 CTRB1 F7	8.66e-04	115	69	4	PS50240
Domain	IGFBP_N_1	CCN5 CCN3	8.67e-04	12	69	2	PS00222
Domain	Tryp_SPc	PRSS12 CTRB2 CTRB1 F7	9.24e-04	117	69	4	SM00020
Domain	Trypsin	PRSS12 CTRB2 CTRB1 F7	1.05e-03	121	69	4	PF00089
Domain	Trypsin_dom	PRSS12 CTRB2 CTRB1 F7	1.05e-03	121	69	4	IPR001254
Domain	Peptidase_S1_PA	PRSS12 CTRB2 CTRB1 F7	1.11e-03	123	69	4	IPR009003
Domain	EGF_extracell	JAG2 MEGF6 ATRNL1	1.42e-03	60	69	3	IPR013111
Domain	EGF_2	JAG2 MEGF6 ATRNL1	1.42e-03	60	69	3	PF07974
Domain	EMI_domain	MEGF6 PEAR1	1.56e-03	16	69	2	IPR011489
Domain	TSP_1	CCN5 SSPOP CCN3	1.64e-03	63	69	3	PF00090
Domain	EGF	JAG2 MEGF6 ATRNL1 F7 PEAR1	1.77e-03	235	69	5	SM00181
Domain	TSP1	CCN5 SSPOP CCN3	1.79e-03	65	69	3	SM00209
Domain	TSP1_rpt	CCN5 SSPOP CCN3	1.79e-03	65	69	3	IPR000884
Domain	TSP1	CCN5 SSPOP CCN3	1.79e-03	65	69	3	PS50092
Domain	CTCK_1	SSPOP CCN3	1.98e-03	18	69	2	PS01185
Domain	IB	CCN5 CCN3	1.98e-03	18	69	2	SM00121
Domain	VWC_out	JAG2 SSPOP	2.21e-03	19	69	2	SM00215
Domain	EGF-like_dom	JAG2 MEGF6 ATRNL1 F7 PEAR1	2.27e-03	249	69	5	IPR000742
Domain	IGFBP-like	CCN5 CCN3	2.45e-03	20	69	2	IPR000867
Domain	IGFBP	CCN5 CCN3	2.45e-03	20	69	2	PF00219
Domain	IGFBP_N_2	CCN5 CCN3	2.45e-03	20	69	2	PS51323
Domain	-	HECTD3 SSPOP EPHA7	2.49e-03	73	69	3	2.60.120.260
Domain	Ricin_B_lectin	GALNT8 GALNT5	3.82e-03	25	69	2	PF00652
Pathway	PID_HEDGEHOG_GLI_PATHWAY	RBBP7 PRKCD PTCH1 SSPOP	3.55e-05	48	55	4	M219
Pathway	WP_FATTY_ACID_BIOSYNTHESIS	ACSL3 ACSL4 ACLY	8.21e-05	22	55	3	M39440
Pathway	WP_FATTY_ACID_BIOSYNTHESIS	ACSL3 ACSL4 ACLY	9.42e-05	23	55	3	MM15885
Pathway	REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	ACSL3 ACSL4 ACLY	2.57e-04	32	55	3	MM15446
Pubmed	The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.	CTRB2 CTRB1	4.23e-06	2	72	2	28951524
Pubmed	Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.	CTRB2 CTRB1	4.23e-06	2	72	2	28754779
Pubmed	No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	19874556
Pubmed	Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	27708262
Pubmed	Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DS1 in a transplant population.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	18331531
Pubmed	Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	16805919
Pubmed	Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	19211742
Pubmed	Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA.	CTRB2 CTRB1	4.23e-06	2	72	2	2917002
Pubmed	Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	35192601
Pubmed	Genomic cloning and partial characterization of human chymotrypsinogen gene.	CTRB2 CTRB1	4.23e-06	2	72	2	8186414
Pubmed	Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.	ACSL3 ACSL4	4.23e-06	2	72	2	32286604
Pubmed	Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	37647275
Pubmed	Association of the KIR3DS1013 and KIR3DL1004 alleles with susceptibility to ankylosing spondylitis.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	20131260
Pubmed	NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes.	NAPEPLD LRRK2	4.23e-06	2	72	2	33706934
Pubmed	Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	25112829
Pubmed	Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	17694054
Pubmed	Contribution of functional KIR3DL1 to ankylosing spondylitis.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	20818412
Pubmed	MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development.	PTCH1 DICER1	4.23e-06	2	72	2	26773048
Pubmed	The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.	ACSL3 ACSL4	4.23e-06	2	72	2	29450800
Pubmed	A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	23524032
Pubmed	Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice.	CTRB2 CTRB1	4.23e-06	2	72	2	30076839
Pubmed	Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	30365992
Pubmed	Tim4 regulates NALP3 inflammasome expression and activity during monocyte/macrophage dysfunction in septic shock patients.	TIMD4 NLRP3	4.23e-06	2	72	2	31676250
Pubmed	Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	17182560
Pubmed	Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis.	CTRB2 CTRB1	4.23e-06	2	72	2	33036922
Pubmed	Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	19008943
Pubmed	Evolutionary relationships between laboratory mice and subspecies of Mus musculus based on the restriction fragment length variants of the chymotrypsin gene at the Prt-2 locus.	CTRB2 CTRB1	4.23e-06	2	72	2	2565717
Pubmed	HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	19386717
Pubmed	Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	28942035
Pubmed	The profile of KIR3DL1 and KIR3DS1 alleles in an African American population resembles that found in African populations.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	20230527
Pubmed	Dicer regulates activation of the NLRP3 inflammasome.	DICER1 NLRP3	4.23e-06	2	72	2	31013297
Pubmed	Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	11098931
Pubmed	Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.	KIR3DL1 KIR3DS1	4.23e-06	2	72	2	19411600
Pubmed	Tim4 recognizes carbon nanotubes and mediates phagocytosis leading to granuloma formation.	TIMD4 NLRP3	4.23e-06	2	72	2	33567275
Pubmed	Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.	ACSL3 ACSL4	4.23e-06	2	72	2	28193492
Pubmed	KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.	KIR3DL1 KIR3DS1	1.27e-05	3	72	2	24059286
Pubmed	Genetic study of pancreatic proteinase in mice (Mus musculus): linkage of the Prt-2 locus on chromosome 8.	CTRB2 CTRB1	1.27e-05	3	72	2	1016231
Pubmed	Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.	KIR3DL1 KIR3DS1	1.27e-05	3	72	2	11859120
Pubmed	Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).	CCN5 CCN3	1.27e-05	3	72	2	27471094
Pubmed	Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies.	KIR3DL1 KIR3DS1	1.27e-05	3	72	2	17301953
Pubmed	Evolutionary expansion of polyaspartate motif in the activation peptide of mouse cationic trypsinogen limits autoactivation and protects against pancreatitis.	CTRB2 CTRB1	1.27e-05	3	72	2	34643096
Pubmed	Loss of chymotrypsin-like protease (CTRL) alters intrapancreatic protease activation but not pancreatitis severity in mice.	CTRB2 CTRB1	1.27e-05	3	72	2	32678161
Pubmed	Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals.	KIR3DL1 KIR3DS1	1.27e-05	3	72	2	12826375
Pubmed	Secretagogue-induced pancreatitis in mice devoid of chymotrypsin.	CTRB2 CTRB1	1.27e-05	3	72	2	38981616
Pubmed	KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.	KIR3DL1 KIR3DS1	1.27e-05	3	72	2	19859704
Pubmed	Genetic study of pancreatic proteinase in mice (Mus musculus): genetic variants of trypsin and chymotrypsin.	CTRB2 CTRB1	1.27e-05	3	72	2	1008801
Pubmed	Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.	KIR3DL1 KIR3DS1	1.27e-05	3	72	2	19019897
Pubmed	Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer.	PIWIL4 DICER1	2.53e-05	4	72	2	14749716
Pubmed	Expression profile of KIR3DS1/KIR3DL1 receptors in association with immunological responses in TB, HIV and HIV/TB infected patients.	KIR3DL1 KIR3DS1	2.53e-05	4	72	2	37169313
Pubmed	Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.	KIR3DL1 KIR3DS1	2.53e-05	4	72	2	27455421
Pubmed	Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.	CCN5 CCN3	2.53e-05	4	72	2	20010302
Pubmed	Activating KIR genes are associated with ankylosing spondylitis in Asian populations.	KIR3DL1 KIR3DS1	2.53e-05	4	72	2	18638658
Pubmed	Polymorphism and domain variability of human killer cell inhibitory receptors.	KIR3DL1 KIR3DS1	2.53e-05	4	72	2	9059894
Pubmed	High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.	KIR3DL1 KIR3DS1	2.53e-05	4	72	2	19522772
Pubmed	Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia.	PRKCD NLRP3	2.53e-05	4	72	2	31036561
Pubmed	The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated.	KIR3DL1 KIR3DS1	2.53e-05	4	72	2	15580659
Pubmed	Biosynthesis of triacylglycerols.	ACSL3 ACSL4 ACLY	2.69e-05	28	72	3	8944226
Pubmed	DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs.	PRKCD NLRP3	4.21e-05	5	72	2	34860583
Pubmed	Chromosomal assignments of genes for trypsin, chymotrypsin B, and elastase in mouse.	CTRB2 CTRB1	4.21e-05	5	72	2	6589791
Pubmed	Genetic study of pancreatic proteinase and alpha-amylase in mice (Mus musculus).	CTRB2 CTRB1	4.21e-05	5	72	2	4461036
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.	KIR3DL1 KIR3DS1	4.21e-05	5	72	2	16508981
Pubmed	Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family.	ACSL3 ACSL4	4.21e-05	5	72	2	15292367
Pubmed	Genetic and biochemical characterization of a new chymotrypsin isozyme of the house mouse, CTRA-1.	CTRB2 CTRB1	4.21e-05	5	72	2	1820020
Pubmed	The Sjögren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway.	ACSL3 ACSL4	4.21e-05	5	72	2	22633490
Pubmed	Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes.	KIR3DL1 KIR3DS1	4.21e-05	5	72	2	17990989
Pubmed	Roles of MIWI, MILI and PLD6 in small RNA regulation in mouse growing oocytes.	PIWIL4 DICER1	6.31e-05	6	72	2	28115634
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.	KIR3DL1 KIR3DS1	6.31e-05	6	72	2	20528243
Pubmed	Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkcδ.	PRKCD NLRP3	6.31e-05	6	72	2	24516390
Pubmed	Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.	CTRB2 CTRB1	6.31e-05	6	72	2	23814066
Pubmed	Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).	CCN5 CCN3	6.31e-05	6	72	2	26498181
Pubmed	Dicer Is Required for Normal Cerebellar Development and to Restrain Medulloblastoma Formation.	PTCH1 DICER1	8.82e-05	7	72	2	26091048
Pubmed	Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.	KIR3DL1 KIR3DS1	8.82e-05	7	72	2	9430220
Pubmed	Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart.	ACSL3 ACSL4	8.82e-05	7	72	2	17197235
Pubmed	HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.	KIR3DL1 KIR3DS1	1.17e-04	8	72	2	27649529
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR3DL1 KIR3DS1	1.17e-04	8	72	2	17200871
Pubmed	Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells.	RPGRIP1 PTCH1	1.17e-04	8	72	2	18297065
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR3DL1 KIR3DS1	1.17e-04	8	72	2	9430221
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	ACSL3 RBBP7 BYSL ZNF622 NSUN2 METTL17 DICER1	1.40e-04	547	72	7	37267103
Pubmed	Identification of eight members of the Argonaute family in the human genome.	PIWIL4 DICER1	1.51e-04	9	72	2	12906857
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR3DL1 KIR3DS1	1.51e-04	9	72	2	8662091
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR3DL1 KIR3DS1	1.51e-04	9	72	2	18340360
Pubmed	Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study.	PIWIL4 DICER1	1.88e-04	10	72	2	20721975
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR3DL1 KIR3DS1	1.88e-04	10	72	2	21206914
Pubmed	Dicer-dependent pathways regulate chondrocyte proliferation and differentiation.	PTCH1 DICER1	2.30e-04	11	72	2	18238902
Pubmed	Natural killer cells and immune surveillance.	KIR3DL1 KIR3DS1	2.30e-04	11	72	2	18830515
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR3DL1 KIR3DS1	2.30e-04	11	72	2	19664392
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	ACSL4 EML5 NAPEPLD ACLY LRRK2 PRKCD NDRG3 CBR1 CA4	2.45e-04	1016	72	9	19056867
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	JAG2 MEGF6 SACS BYSL JADE1 SSPOP METTL17	2.66e-04	608	72	7	16713569
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR3DL1 KIR3DS1	2.75e-04	12	72	2	20371502
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR3DL1 KIR3DS1	2.75e-04	12	72	2	17490516
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR3DL1 KIR3DS1	2.75e-04	12	72	2	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR3DL1 KIR3DS1	2.75e-04	12	72	2	19181658
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR3DL1 KIR3DS1	2.75e-04	12	72	2	20137308
Pubmed	Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.	ACSL3 CLGN HECTD3 ZNF622 DICER1	3.09e-04	283	72	5	21903422
Pubmed	Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.	CCN5 CCN3	3.25e-04	13	72	2	18597638
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR3DL1 KIR3DS1	3.25e-04	13	72	2	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR3DL1 KIR3DS1	3.25e-04	13	72	2	19120281
Pubmed	Defective folate metabolism causes germline epigenetic instability and distinguishes Hira as a phenotype inheritance biomarker.	PTCH1 NSUN2	3.25e-04	13	72	2	34140513
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR3DL1 KIR3DS1	3.25e-04	13	72	2	18687225
Pubmed	Characterization of a novel gene, sperm-tail-associated protein (Stap), in mouse post-meiotic testicular germ cells.	CTRB2 CTRB1	3.25e-04	13	72	2	11468771
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	PAPPA2 CSMD1 CR1L F13B	1.69e-05	57	49	4	1179
GeneFamily	CYR61/CTGF/NOV matricellular proteins	CCN5 CCN3	1.07e-04	6	49	2	1046
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR3DL1 KIR3DS1	1.07e-03	18	49	2	620
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT8 GALNT5	1.33e-03	20	49	2	433
GeneFamily	Acyl-CoA synthetase family	ACSL3 ACSL4	2.24e-03	26	49	2	40
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACSL4 SLC6A11 LRRK2 GALNT5 SLC22A31	1.86e-06	127	71	5	5b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCell	LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MEGF6 SACS PRSS12 ERI2 AK8	3.56e-06	145	71	5	90ca38c02325c5c637c32efdef634b54cc3cd105
ToppCell	droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPGRIP1 DISC1 C17orf99 PTCH1 AK8	8.18e-06	172	71	5	24ecfda5e43e28f190089770cd2eae5bf2ed292b
ToppCell	droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPGRIP1 DISC1 C17orf99 PTCH1 AK8	8.18e-06	172	71	5	db5a31cafce4346fe459d7f35210823fd7004439
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MEGF6 PRSS12 ATRNL1 PTCH1 EPHA7	1.10e-05	183	71	5	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACSL4 EML5 LRRK2 GALNT5 SLC22A31	1.13e-05	184	71	5	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRSS12 DISC1 KIAA0232 FAM178B LRRK2	1.26e-05	188	71	5	c2febf9fd4632af1f922067c3a30e5c50f75f480
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ACSL4 EML5 LRRK2 GALNT5 SLC22A31	1.58e-05	197	71	5	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	lung-Type_II_Pneumocytes\|lung / shred on tissue and cell subclass	ACSL4 LRRK2 GALNT5 SLC22A31	8.97e-05	147	71	4	8a3039de45b8087f8319e2e37329acf7278219b7
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	JAG2 CD164L2 TRBV5-1 F7	9.69e-05	150	71	4	98fdc6bdfde84d680e11d8727502b79afbf64303
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	C17orf99 FAM178B BYSL GALNT5	9.95e-05	151	71	4	8ba15ab24fe2e71df0a2a7511ca451ad2376bd91
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	EML5 GALNT8 SLC38A8 TRIM60	1.07e-04	154	71	4	df1b58a20af73fa79c6c069c0117a9ffd85b476f
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TIMD4 MEGF6 PRKCD PTCH1	1.21e-04	159	71	4	1472536eea61d4f13033efe42f128bae1614fa74
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LRRK2 PIWIL4 CA4 SLC22A31	1.24e-04	160	71	4	bb1bb3673059768c0ea0160d29fff127f3a4ecb4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 PRSS12 FAM178B PRKCD	1.27e-04	161	71	4	c54010d88f1ecb6e0235bb66084876a4d5bf1ecd
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD164L2 ACSL4 FAM178B PIWIL4	1.30e-04	162	71	4	8e0f03fcc25b2ea777e8478fbf771699cf93719c
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD164L2 ACSL4 FAM178B PIWIL4	1.30e-04	162	71	4	e0417f1242edf71934fe62bccc55c4678f7ff4ac
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTCH1 LY75 NDRG3 NLRP3	1.47e-04	167	71	4	b742558ca92985db0a67c88f530bc375f3d3bb98
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLGN TIMD4 LY75 SSPOP	1.64e-04	172	71	4	c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f
ToppCell	facs-Lung-EPCAM-18m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLGN TIMD4 LY75 SSPOP	1.64e-04	172	71	4	7c085c02b59e24e2a2cd393b5e692f9fb19257fe
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(Ndrg2)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	GALNT5 AK8 F13B	1.83e-04	69	71	3	3f6902cb62d6130b3d3a1cf122dbc695f7349ffe
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(Ndrg2)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	GALNT5 AK8 F13B	1.83e-04	69	71	3	832ed163f553481b49bbf8a1eb10cbd8afab4e34
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	NAPEPLD AZIN2 KIAA0232 LRRK2	1.91e-04	179	71	4	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACSL4 LRRK2 GALNT5 SLC22A31	1.91e-04	179	71	4	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS12 ATRNL1 PTCH1 EPHA7	1.91e-04	179	71	4	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	ASK454-Endothelial-Lymphatic\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	CCN5 RPGRIP1 NAPEPLD PEAR1	1.91e-04	179	71	4	fd84a79f76a01c0377dff5b20016b004d369f96f
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	C17orf99 FAM178B GALNT5 CR1L	2.08e-04	183	71	4	1db466cf757813322db1cdcc0bf1d91c062fd9de
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ACSL4 LRRK2 CA4	2.12e-04	184	71	4	d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ACSL4 LRRK2 CA4	2.12e-04	184	71	4	8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACSL4 LRRK2 GALNT5 SLC22A31	2.17e-04	185	71	4	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ACSL4 LRRK2 CA4	2.17e-04	185	71	4	74b787e225d83efcb84e79c23499febe1a106622
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACSL4 LRRK2 GALNT5 SLC22A31	2.21e-04	186	71	4	e83718fabb057100835d3357df407f283d23fe16
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Inhba_(CA3_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLC7A9 GALNT5 SLC38A8	2.25e-04	74	71	3	29d94713d97ac44e0f83d2f3609a719650e20d0f
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACSL4 LRRK2 GALNT5 SLC22A31	2.31e-04	188	71	4	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	MEGF6 AZIN2 NLRP3 PEAR1	2.31e-04	188	71	4	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	15-Distal-RBC\|Distal / Age, Tissue, Lineage and Cell class	C17orf99 FAM178B CR1L F7	2.31e-04	188	71	4	c68ccb1c5c21d13ddac09b16e7d466f0530bbda5
ToppCell	15-Distal-RBC-RBC\|Distal / Age, Tissue, Lineage and Cell class	C17orf99 FAM178B CR1L F7	2.31e-04	188	71	4	2534684e4932c1255c24a26ca2277ac7af0a118b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ACSL4 LRRK2 CA4	2.35e-04	189	71	4	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MEGF6 LRRK2 GALNT5 SLC22A31	2.35e-04	189	71	4	2d32f09efa982ae458568f6b1cd06bb5078d42a3
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ACSL4 CCN3 CA4	2.40e-04	190	71	4	498bbe063bc75d323cb186a82cce122b511d2cff
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PIWIL4 GALNT5 SSPOP	2.44e-04	76	71	3	efbbbf91bca35720d8ecddb076f2c9f4de25e44d
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PIWIL4 GALNT5 SSPOP	2.44e-04	76	71	3	254d18bece2676faa4bbeb8d48b1d327ab3c2215
ToppCell	Myeloid-Myeloid-B_(Activated_Macrophage)\|Myeloid / shred on cell class and cell subclass (v4)	ACSL4 LY75 F7 CA4	2.45e-04	191	71	4	7bf125249af1e8bb138ed4d999fdd74b03ab2447
ToppCell	proximal-Hematologic-Platelet/Megakaryocyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DISC1 C17orf99 FAM178B PIWIL4	2.50e-04	192	71	4	522d1bb15edf1d6006b80289bd3baadb99584ae8
ToppCell	proximal-3-Hematologic-Platelet/Megakaryocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DISC1 C17orf99 FAM178B PIWIL4	2.50e-04	192	71	4	f5f83dec37dff32a0c471cb05d23d13b0b0ad0c9
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACSL4 MEGF6 LRRK2 SLC22A31	2.50e-04	192	71	4	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	proximal-Hematologic-Platelet/Megakaryocyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DISC1 C17orf99 FAM178B PIWIL4	2.50e-04	192	71	4	57899a905ca3e336bb7f31edc6418a2546b9891a
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	C17orf99 GALNT5 LY75	2.53e-04	77	71	3	dbbefd2dfa4c345172cb5a995952e3682fbadf92
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	ACSL3 LRRK2 CSMD1 NLRP3	2.60e-04	194	71	4	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	TCGA-Thryoid-Primary_Tumor\|TCGA-Thryoid / Sample_Type by Project: Shred V9	JAG2 HECTD3 LRRK2 SLC22A31	2.65e-04	195	71	4	7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma\|TCGA-Thryoid / Sample_Type by Project: Shred V9	JAG2 HECTD3 LRRK2 SLC22A31	2.65e-04	195	71	4	b61b8c931bd0ca3678486653ae1d7e9915c696c7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ACSL4 CCN3 CA4	2.70e-04	196	71	4	d688350aadc622984d612ae6b2fd7c0113a4ec0f
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EML5 GALNT5 AK8 SLC22A31	2.75e-04	197	71	4	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.75e-04	197	71	4	ad6f047d003c08413264f39a30ba0f7639a257cd
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.75e-04	197	71	4	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.75e-04	197	71	4	1638959d7aecb9fc5285eb7e4a3103ca437989e2
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.81e-04	198	71	4	d087e738d69ca9853553fde46d4e7a8906439d32
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ACSL4 CBR1 CA4	2.81e-04	198	71	4	688b0eb5534dde40b8630ab8a3252c816711e02e
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ACSL4 MEGF6 LRRK2 SLC22A31	2.81e-04	198	71	4	85215015bb86ada0e871c413a4ecdc903a3785ca
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.81e-04	198	71	4	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ACSL4 CBR1 CA4	2.81e-04	198	71	4	4448d13511485a44fe7b549e4b8b6ad7637db624
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_only / Treatment groups by lineage, cell group, cell type	FAM178B PRKCD JADE1 EPHA7	2.81e-04	198	71	4	d205dfcfe1f20e1e21bf84759e723d9e6e610a5c
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.81e-04	198	71	4	d12f37527399038a8f030b45b176bda5c7c8a7ad
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.81e-04	198	71	4	c4e7512f0e1d115f2be8acae6048eda8b6b640b2
ToppCell	LPS_anti-TNF-Epithelial_alveolar\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.81e-04	198	71	4	53e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.81e-04	198	71	4	aa80315395cb5dffc25927c8a77cd2037aea8772
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.81e-04	198	71	4	655df75b9692d815c7f6910275e1f684ac63bf62
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.81e-04	198	71	4	82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ACSL4 MEGF6 LRRK2 SLC22A31	2.81e-04	198	71	4	38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Man1a_(Man1a)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GALNT5 SSPOP F7	2.84e-04	80	71	3	d42b72ef822f731ff5ff1d04216e91f414c5556e
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Man1a_(Man1a)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GALNT5 SSPOP F7	2.84e-04	80	71	3	d3ee8fc9b2cb47ee476f4cd8b9fcba14cb9ca759
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor\|LPS_only / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.86e-04	199	71	4	3a0af1a13b1760f4213d87d0958dbe3bf3b9a42b
ToppCell	LPS_IL1RA-Epithelial_alveolar\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.86e-04	199	71	4	5b140ac88ebc25ce397ae577e48f3e271faf46e7
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRSS12 ATRNL1 PTCH1 EPHA7	2.86e-04	199	71	4	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Biopsy_IPF-Epithelial-Transitional_AT2\|Biopsy_IPF / Sample group, Lineage and Cell type	MEGF6 LRRK2 GALNT5 SLC22A31	2.86e-04	199	71	4	83ff8b7e472d1212324c05cc719b746d19e5e23b
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRSS12 ATRNL1 PTCH1 EPHA7	2.86e-04	199	71	4	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.86e-04	199	71	4	0447f8f53389fe7c6ddc04a97d86e74122ea16f4
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_only / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.86e-04	199	71	4	7b21447bb39cdba37539a12cb475f463010fc23f
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACSL4 MEGF6 LRRK2 SLC22A31	2.86e-04	199	71	4	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ACSL4 LRRK2 GALNT5 SLC22A31	2.92e-04	200	71	4	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PAPPA2 PRSS12 ATRNL1 PTCH1	2.92e-04	200	71	4	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PRSS12 ATRNL1 PTCH1 EPHA7	2.92e-04	200	71	4	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	EML5 KIAA0232 GALNT5 SLC22A31	2.92e-04	200	71	4	eac33be484dc443794e66e473f03e98406c2983e
Drug	c189	CTRB2 CTRB1	9.32e-06	2	70	2	CID000248048
Drug	BOCPheONP	CTRB2 CTRB1	9.32e-06	2	70	2	CID000111308
Drug	dansyl-D-arginine methyl ester	CTRB2 CTRB1	9.32e-06	2	70	2	CID000191369
Drug	MPM-06	CTRB2 CTRB1	9.32e-06	2	70	2	CID000161546
Drug	methyl 6-phenylhexanoate	CTRB2 CTRB1	9.32e-06	2	70	2	CID011820300
Drug	NSC-374899	CTRB2 CTRB1	9.32e-06	2	70	2	CID000435726
Drug	5-aminotetrazole	CTRB2 CTRB1	9.32e-06	2	70	2	CID000020467
Drug	2-bromoisobutyric acid	CTRB2 CTRB1	9.32e-06	2	70	2	CID000074924
Drug	p-toluamidine	CTRB2 CTRB1	9.32e-06	2	70	2	CID000122753
Drug	methylbenzenebutanoate	CTRB2 CTRB1	9.32e-06	2	70	2	CID000281254
Drug	N-acetyl-alpha-azaphenylalanine phenyl ester	CTRB2 CTRB1	9.32e-06	2	70	2	CID000191275
Drug	Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu	CTRB2 CTRB1	9.32e-06	2	70	2	CID004418081
Drug	isobutyl sulfide	CTRB2 CTRB1	9.32e-06	2	70	2	CID000011607
Drug	zLYCK	NAPEPLD CTRB2 CTRB1	1.51e-05	16	70	3	CID000171556
Drug	methylcyclopentadienyl manganese tricarbonyl	CTRB2 PRKCD CTRB1	1.83e-05	17	70	3	CID000025511
Drug	3-amino-2-pyridone	CTRB2 CTRB1	2.79e-05	3	70	2	CID000322353
Drug	ASA-BMPA	CTRB2 CTRB1	2.79e-05	3	70	2	CID003035649
Drug	p-nitrophenyl benzoate	CTRB2 CTRB1	2.79e-05	3	70	2	CID000070396
Drug	N-acetylbenzotriazole	CTRB2 CTRB1	2.79e-05	3	70	2	CID000087784
Drug	Z-Phe-OMe	CTRB2 CTRB1	2.79e-05	3	70	2	CID003082435
Drug	photophor	CTRB2 CTRB1	2.79e-05	3	70	2	CID000014780
Drug	3-methylcoumarin	CTRB2 CTRB1	2.79e-05	3	70	2	CID000017130
Drug	dibutyl iodomethaneboronate	CTRB2 CTRB1	2.79e-05	3	70	2	CID000098591
Drug	zinc;dipicolinate	CTRB2 CTRB1	2.79e-05	3	70	2	CID004309911
Drug	2-propyl methylphosphonochloridate	CTRB2 CTRB1	2.79e-05	3	70	2	CID000102124
Drug	2-oxobut-3-ynoate	CTRB2 CTRB1	2.79e-05	3	70	2	CID000171547
Drug	AFMeq	CTRB2 CTRB1	2.79e-05	3	70	2	CID000194069
Drug	Bz-Cti-otbu	CTRB2 CTRB1	2.79e-05	3	70	2	CID006452691
Drug	n-(2-oxoethyl)benzamide	CTRB2 CTRB1	2.79e-05	3	70	2	CID000188995
Drug	AC1L49DM	CTRB2 CTRB1	2.79e-05	3	70	2	CID000152933
Drug	FK-316	CTRB2 CTRB1	2.79e-05	3	70	2	CID000133688
Drug	AC1L19T8	CTRB2 CTRB1	2.79e-05	3	70	2	CID000000694
Drug	Marinostatin D	CTRB2 CTRB1	2.79e-05	3	70	2	CID000132206
Drug	c140	CTRB2 CTRB1	2.79e-05	3	70	2	CID002783250
Drug	1FD7	CTRB2 CTRB1	2.79e-05	3	70	2	CID000445579
Drug	Benzamidomethaneboronic acid	CTRB2 CTRB1	2.79e-05	3	70	2	CID000127677
Drug	phenyl hippurate	CTRB2 CTRB1	2.79e-05	3	70	2	CID000076323
Drug	FK-386	CTRB2 CTRB1	2.79e-05	3	70	2	CID000135044
Drug	FK-375	CTRB2 CTRB1	2.79e-05	3	70	2	CID000135042
Drug	carbostyril-124	CTRB2 CTRB1	2.79e-05	3	70	2	CID000088277
Drug	N-trifluoroacetyl-4-fluorophenylalanine	CTRB2 CTRB1	2.79e-05	3	70	2	CID000328214
Drug	Glt-leu-phe-nh-meq	CTRB2 CTRB1	2.79e-05	3	70	2	CID000194914
Drug	AC1L4Z4F	CTRB2 CTRB1	2.79e-05	3	70	2	CID000194913
Drug	Glt-Phe-NH-FMeq	CTRB2 CTRB1	2.79e-05	3	70	2	CID000194912
Drug	C18 4	CTRB2 CTRB1	2.79e-05	3	70	2	CID000077248
Drug	diacetyl trimer	CTRB2 CTRB1	2.79e-05	3	70	2	CID000193527
Drug	FK-448	CTRB2 CTRB1	2.79e-05	3	70	2	CID006917869
Drug	Ac-Phe-OMe	CTRB2 CTRB1	2.79e-05	3	70	2	CID000097805
Drug	taraxastane	CTRB2 CTRB1	2.79e-05	3	70	2	CID006429404
Drug	thiobenzyl N-heptafluorobutyrylanthranilate	CTRB2 CTRB1	2.79e-05	3	70	2	CID000133906
Drug	Phe-phe-ome	CTRB2 CTRB1	2.79e-05	3	70	2	CID000151728
Drug	phenylethaneboronic acid	CTRB2 CTRB1	2.79e-05	3	70	2	CID000065389
Drug	F-Ct	CTRB2 CTRB1 CBR1	3.06e-05	20	70	3	CID000445968
Drug	AC1NRB18	CTRB2 CTRB1 CBR1	3.56e-05	21	70	3	CID005288203
Drug	Benzoyl-dl-leucine	CTRB2 CTRB1	5.57e-05	4	70	2	CID000294887
Drug	Acafcek	CTRB2 CTRB1	5.57e-05	4	70	2	CID000197677
Drug	p-fluorobenzenesulfonyl chloride	CTRB2 CTRB1	5.57e-05	4	70	2	CID000009588
Drug	BSSDA	CTRB2 CTRB1	5.57e-05	4	70	2	CID003081106
Drug	B-1,3-od	CTRB2 CTRB1	5.57e-05	4	70	2	CID011971053
Drug	AC1L2HV6	CTRB2 CTRB1	5.57e-05	4	70	2	CID000047328
Drug	dehydromerodesmosine	CTRB2 CTRB1	5.57e-05	4	70	2	CID006443540
Drug	AC1L4X1Z	CTRB2 CTRB1	5.57e-05	4	70	2	CID000193815
Drug	alpha-amyrin palmitate	CTRB2 CTRB1	5.57e-05	4	70	2	CID000185477
Drug	poly-THIQ	CTRB2 CTRB1	5.57e-05	4	70	2	CID006453487
Drug	NSC-676827	CTRB2 CTRB1	5.57e-05	4	70	2	CID000385555
Drug	N-(4-carboxycyclohexylmethyl)-maleimide	CTRB2 CTRB1	5.57e-05	4	70	2	CID011548799
Drug	G2505_sigma	CTRB2 CTRB1	5.57e-05	4	70	2	CID000111098
Drug	6-amino-1,2-benzopyrone	CTRB2 CTRB1	5.57e-05	4	70	2	CID000046152
Drug	nitrophenylethanol	CTRB2 CTRB1	5.57e-05	4	70	2	CID000097851
Drug	7-chloro-4-nitrobenzofuran	CTRB2 CTRB1	9.26e-05	5	70	2	CID000130782
Drug	Ac-Trp-OEt	CTRB2 CTRB1	9.26e-05	5	70	2	CID000304749
Drug	Z-Phe-Leu	CTRB2 CTRB1	9.26e-05	5	70	2	CID000333351
Drug	5'-FSBAzA	CTRB2 CTRB1	9.26e-05	5	70	2	CID000130430
Drug	AC1L3F57	CTRB2 CTRB1	9.26e-05	5	70	2	CID000139565
Drug	apne	CTRB2 CTRB1	9.26e-05	5	70	2	CID000098192
Drug	3,5-dimethylpyrazole-1-carboxamidine	CTRB2 CTRB1	9.26e-05	5	70	2	CID000097525
Drug	Maap-borov	CTRB2 CTRB1	9.26e-05	5	70	2	CID005486914
Drug	2-amino-4,6-dichlorotriazine	CTRB2 CTRB1	9.26e-05	5	70	2	CID000013615
Drug	AC1O52A0	CTRB2 CTRB1	9.26e-05	5	70	2	CID006475891
Drug	allysine aldol	CTRB2 CTRB1	9.26e-05	5	70	2	CID000191270
Drug	mangrove	ACSL3 ACSL4 NAPEPLD CTRB2 PRKCD PTCH1 CTRB1 F7	9.28e-05	468	70	8	CID000000965
Drug	octyl isocyanate	CTRB2 CTRB1	1.39e-04	6	70	2	CID000076616
Drug	Asp-Asp-Asp-Asp	CTRB2 CTRB1	1.39e-04	6	70	2	CID004432006
Drug	N-benzoyl-L-tyrosine thiobenzyl ester	CTRB2 CTRB1	1.39e-04	6	70	2	CID000191444
Drug	Leupeptin acid	CTRB2 CTRB1	1.39e-04	6	70	2	CID000189069
Drug	Sri 8835	CTRB2 CTRB1	1.39e-04	6	70	2	CID000479975
Drug	N,N-dimethylglycylbenzocaine	CTRB2 CTRB1	1.39e-04	6	70	2	CID000188251
Drug	N-benzoyltyrosine butylamide	CTRB2 CTRB1	1.39e-04	6	70	2	CID000125261
Drug	D-gluconyl-glycine azide	CTRB2 CTRB1	1.39e-04	6	70	2	CID000194550
Drug	2-azidoatrazine	CTRB2 CTRB1	1.39e-04	6	70	2	CID003032432
Drug	L-659,286	CTRB2 CTRB1	1.39e-04	6	70	2	CID000128954
Drug	bz-Ala-OMe	CTRB2 CTRB1	1.39e-04	6	70	2	CID000023671
Drug	FK480	CTRB2 CTRB1	1.39e-04	6	70	2	CID000132916
Drug	Maap-borof	CTRB2 CTRB1	1.39e-04	6	70	2	CID005492190
Drug	AC1L4DZ7	CTRB2 CTRB1	1.39e-04	6	70	2	CID000155288
Drug	cobalt;(6E)-6-[[2-[[(E)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]ethylamino]methylene]cyclohexa-2,4-dien-1-one;hydrate	CTRB2 CTRB1	1.39e-04	6	70	2	CID011810022
Drug	soman	CTRB2 PRKCD CTRB1 CA4	1.87e-04	92	70	4	CID000007305
Drug	dinonylnaphthalene	CTRB2 CTRB1	1.94e-04	7	70	2	CID003015220
Drug	m-aminobenzamidine	CTRB2 CTRB1	1.94e-04	7	70	2	CID000197789
Drug	methyl p-nitrobenzenesulfonate	CTRB2 CTRB1	1.94e-04	7	70	2	CID000022582
Disease	level of chymotrypsinogen B2 in blood serum	CTRB2 CTRB1	5.39e-06	2	69	2	OBA_2041192
Disease	non-syndromic X-linked intellectual disability 63 (implicated_via_orthology)	ACSL3 ACSL4	5.39e-06	2	69	2	DOID:0112050 (implicated_via_orthology)
Disease	chymotrypsinogen B measurement	CTRB2 CTRB1	1.61e-05	3	69	2	EFO_0801477
Disease	chronic fatigue syndrome (is_implicated_in)	DISC1 KIR3DS1	5.36e-05	5	69	2	DOID:8544 (is_implicated_in)
Disease	Sjogren-Larsson syndrome (implicated_via_orthology)	ACSL3 ACSL4	8.03e-05	6	69	2	DOID:14501 (implicated_via_orthology)
Disease	metachronous colorectal adenoma	SLC6A11 NLRP3 EPHA7	1.62e-04	45	69	3	EFO_0803377
Disease	non-syndromic X-linked intellectual disability (implicated_via_orthology)	ACSL3 ACSL4	1.92e-04	9	69	2	DOID:0050776 (implicated_via_orthology)
Disease	NG-monomethyl-arginine measurement	SLC7A9 CSMD1	2.92e-04	11	69	2	EFO_0010510
Disease	Basal cell carcinoma	XPC PTCH1	2.92e-04	11	69	2	C0007117
Disease	trypsin-2 measurement	CTRB2 CTRB1	2.92e-04	11	69	2	EFO_0008305
Disease	antisaccade response measurement	DISC1 GALNT8 CSMD1	3.10e-04	56	69	3	EFO_0006874
Disease	Oligospermia	PIWIL4 DICER1	3.50e-04	12	69	2	C0028960
Disease	hyperglycemia (is_marker_for)	PTCH1 F7	4.13e-04	13	69	2	DOID:4195 (is_marker_for)
Disease	Rhabdomyosarcoma	PTCH1 DICER1	5.55e-04	15	69	2	C0035412
Disease	thyroid peroxidase antibody measurement	ATRNL1 DICER1 TRIM60	6.50e-04	72	69	3	EFO_0005666
Disease	cortical thickness change measurement	CSMD1 EPHA7	8.05e-04	18	69	2	EFO_0021501
Disease	Hemorrhage	F7 EPHA7	9.96e-04	20	69	2	C0019080
Disease	Deep Vein Thrombosis	F7 F13B	1.10e-03	21	69	2	C0149871
Disease	Venous Thrombosis	F7 F13B	1.10e-03	21	69	2	C0042487
Disease	malaria (is_implicated_in)	KIR3DL1 KIR3DS1	1.44e-03	24	69	2	DOID:12365 (is_implicated_in)
Disease	Autosomal Dominant Parkinsonism	LRRK2 PRKCD	1.96e-03	28	69	2	C0752098
Disease	Autosomal Dominant Juvenile Parkinson Disease	LRRK2 PRKCD	1.96e-03	28	69	2	C0752097
Disease	hepatitis C (is_implicated_in)	KIR3DL1 KIR3DS1	1.96e-03	28	69	2	DOID:1883 (is_implicated_in)
Disease	Parkinsonism, Experimental	LRRK2 PRKCD	1.96e-03	28	69	2	C0752101
Disease	Autosomal Recessive Parkinsonism	LRRK2 PRKCD	1.96e-03	28	69	2	C0752100
Disease	Familial Juvenile Parkinsonism	LRRK2 PRKCD	1.96e-03	28	69	2	C0752104
Disease	Ramsay Hunt Paralysis Syndrome	LRRK2 PRKCD	1.96e-03	28	69	2	C0242423
Disease	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	LRRK2 PRKCD	1.96e-03	28	69	2	C1868675
Disease	tuberculosis (is_implicated_in)	KIR3DL1 KIR3DS1	1.96e-03	28	69	2	DOID:399 (is_implicated_in)
Disease	Strabismus	RPGRIP1 CSMD1	2.10e-03	29	69	2	HP_0000486
Disease	Parkinsonism, Juvenile	LRRK2 PRKCD	2.25e-03	30	69	2	C0752105
Disease	Parkinsonian Disorders	LRRK2 PRKCD	2.25e-03	30	69	2	C0242422
Disease	intellectual disability (is_implicated_in)	ACSL4 PRSS12	2.25e-03	30	69	2	DOID:1059 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLICCEIKLKDWQEG	ACSL4	491	O60488
PLVCQKDGAWTLVGI	CTRB2	216	Q6GPI1
EGVPLKICLSQFCKW	ERI2	106	A8K979
DCKVPGDDCPLVWGQ	ANAPC11	36	Q9NYG5
GVWKGEIPQCLPVFC	CSMD1	3141	Q96PZ7
VEGVCKPLSCGWEIT	AZIN2	431	Q96A70
CRAVLVVLGPWCADK	DICER1	306	Q9UPY3
SCKCPLLGKVWEADL	DISC1	681	Q9NRI5
LQCPIVLCGWRGKAS	NSUN2	671	Q08J23
EGLVLINVDPCAKGW	NDRG3	156	Q9UGV2
EGGWACLVCKEKLII	NUP133	111	Q8WUM0
ILLCEKDIWQGGVCP	PRSS12	246	P56730
GKFCIILVCVCWVGG	OR11H6	156	Q8NGC7
LWGLVKQGLKCEDCG	PRKCD	251	Q05655
KCPGSLHIIRWIQGC	HORMAD2	76	Q8N7B1
CGWKPCLLAGQPEAL	JAG2	906	Q9Y219
KLQDLPPCWGLDIVC	KIAA1109	321	Q2LD37
GPLVKSGERVILQCW	KIR3DL1	131	P43629
CEDGKWTEPPKCIEG	F13B	316	P05160
CIKQGWILDGIPETR	AK8	131	Q96MA6
LGPVQTWLGQELEKC	KIAA0232	36	Q92628
EILKCIEECVEPWNG	PGM2L1	201	Q6PCE3
PIDGECVCKEGWQRG	PEAR1	461	Q5VY43
GWSLLCKLIEVCPGT	LRRK2	81	Q5S007
ACDTKLEWVCQIPKG	LY75	781	O60449
SAEGEWLVPIGKCIC	EPHA7	251	Q15375
VCLWDINAGPKEGKI	RBBP7	201	Q16576
KIQCLEGGIWEQGSC	PAPPA2	1576	Q9BXP8
LEVFPKGRWVLITCC	C17orf99	36	Q6UX52
CLVPVKWGGNCQKDR	CA4	36	P22748
VEVPGECCEKWICGP	CCN3	161	P48745
LIKCGEWCIAPIPDK	GALNT5	851	Q7Z7M9
RVWQCGGKVEILPCS	GALNT8	391	Q9NY28
AVGPCLIIWAACGVL	SLC7A9	61	P82251
WDNKTPVCDRIICGL	CR1L	146	Q2VPA4
VEVLGKCCPEWVCGQ	CCN5	151	O76076
EELCKNAGPGIKCVW	ATRNL1	621	Q5VV63
RKGDKILLNACCPGW	CBR1	216	P16152
IWPAVQGACKQLEVC	CD164L2	46	Q6UWJ8
TSVLGLCCEGIWPVI	EML5	1176	Q05BV3
LCCEGIWPVIGEVTD	EML5	1181	Q05BV3
IKIWPIGREINCKCL	FBXW2	301	Q9UKT8
LVCGDGWKVPLEQVS	SLC22A31	121	A6NKX4
LVWKGDLCNLCAPPD	SACS	1171	Q9NZJ4
KCLLTLGRWCPGLGV	METTL17	6	Q9H7H0
WFKGILIPLCESGTC	BYSL	286	Q13895
PLVCQKDGAWTLVGI	CTRB1	216	P17538
CIVVEGPILDCWTCL	IZUMO3	136	Q5VZ72
IPLVCWIVCTGLKQQ	NLRP3	411	Q96P20
GWAGLACEKECLPRD	MEGF6	1066	O75095
EPQNELWIEITKCCG	RPGRIP1	796	Q96KN7
CPCLVGEELKWPGVS	SSPOP	2676	A2VEC9
GKVCPKGECPWQVLL	F7	216	P08709
KGECPWQVLLLVNGA	F7	221	P08709
NIREWPGKLQELCCT	FAM178B	481	Q8IXR5
GPLVKSGERVILQCW	KIR3DS1	131	Q14943
CKLGGELWAVEIPLK	PIWIL4	601	Q7Z3Z4
CLIITPLDCFWEGAK	PTCH1	226	Q13635
GILKVPEGSWLCRTC	JADE1	236	Q6IE81
GPRVKCCLEVWGVVS	SLC38A8	401	A6NNN8
IKEGRLTKPIVCWCI	ACLY	731	P53396
LVCCEIKLKNWEEGG	ACSL3	501	O95573
ILNPACRIGCGEWKP	CLGN	346	O14967
REEPVWLEGTKLCCQ	RNF223	131	E7ERA6
EGGITCWRKVCPLFE	SLC6A11	116	P48066
LCWVLLCPLGEGPVD	TRBV5-7	6	A0A0A0MS05
VGNKPKWILGVCQDC	TRIM60	356	Q495X7
LCWVLLCLLGAGPVK	TRBV5-1	6	A0A578
LCQCKKGVDPIGWIS	ZNF226	196	Q9NYT6
VVIRGLCGEQPMCWE	VWA5B2	841	Q8N398
GEKVGVGKICLWCNE	ZNF622	296	Q969S3
KWVCVDCVHGVVGQP	XPC	541	Q01831
CCRIEVPGWFNDVKI	TIMD4	111	Q96H15
GDCGLQEGWLLVCRP	HECTD3	131	Q5T447
VPLGLLDWMQKCGCE	NAPEPLD	211	Q6IQ20